Ensign Peak Advisors Inc lifted its holdings in Hexcel Co. (NYSE:HXL – Free Report) by 366.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 170,768 shares of the aerospace company’s stock after buying an additional 134,149 shares during the quarter. Ensign Peak Advisors Inc owned about 0.21% of Hexcel worth $10,664,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Fidelis Capital Partners LLC acquired a new position in Hexcel during the 1st quarter worth $36,000. Centerpoint Advisors LLC lifted its stake in shares of Hexcel by 44.6% during the first quarter. Centerpoint Advisors LLC now owns 723 shares of the aerospace company’s stock valued at $53,000 after acquiring an additional 223 shares during the period. Harel Insurance Investments & Financial Services Ltd. bought a new position in Hexcel in the first quarter valued at about $54,000. GAMMA Investing LLC increased its position in Hexcel by 34.8% in the second quarter. GAMMA Investing LLC now owns 1,068 shares of the aerospace company’s stock worth $67,000 after purchasing an additional 276 shares during the period. Finally, Assetmark Inc. raised its holdings in Hexcel by 24.3% during the 4th quarter. Assetmark Inc. now owns 1,497 shares of the aerospace company’s stock worth $110,000 after purchasing an additional 293 shares during the last quarter. Institutional investors and hedge funds own 95.47% of the company’s stock.
Hexcel Price Performance
HXL stock opened at $61.55 on Wednesday. The stock has a 50-day moving average price of $62.44 and a two-hundred day moving average price of $65.84. Hexcel Co. has a 1 year low of $58.54 and a 1 year high of $77.09. The stock has a market cap of $5.12 billion, a PE ratio of 52.61, a price-to-earnings-growth ratio of 1.33 and a beta of 1.29. The company has a current ratio of 2.75, a quick ratio of 1.55 and a debt-to-equity ratio of 0.51.
Hexcel Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 9th. Investors of record on Friday, August 2nd were given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date was Friday, August 2nd. Hexcel’s dividend payout ratio (DPR) is currently 51.28%.
Analyst Ratings Changes
Several brokerages have recently commented on HXL. BMO Capital Markets lowered their price target on shares of Hexcel from $73.00 to $71.00 and set a “market perform” rating for the company in a research report on Friday, July 19th. Royal Bank of Canada cut Hexcel from an “outperform” rating to a “sector perform” rating and decreased their price objective for the stock from $76.00 to $68.00 in a research note on Wednesday, August 14th. Morgan Stanley cut their target price on Hexcel from $63.00 to $61.00 and set an “underweight” rating on the stock in a research note on Monday, July 22nd. UBS Group decreased their target price on Hexcel from $73.00 to $71.00 and set a “neutral” rating for the company in a research report on Monday, July 1st. Finally, Truist Financial reduced their price objective on shares of Hexcel from $88.00 to $81.00 and set a “buy” rating on the stock in a research note on Wednesday, July 17th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, Hexcel currently has a consensus rating of “Hold” and an average target price of $74.54.
Check Out Our Latest Analysis on Hexcel
Hexcel Company Profile
Hexcel Corporation develops, manufactures, and markets carbon fibers, structural reinforcements, honeycomb structures, resins, and composite materials and parts for use in commercial aerospace, space and defense, and industrial applications. It operates through two segments, Composite Materials and Engineered Products.
Recommended Stories
- Five stocks we like better than Hexcel
- With Risk Tolerance, One Size Does Not Fit All
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Are Trending Stocks? Trending Stocks Explained
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Start Investing in Real Estate
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Hexcel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hexcel and related companies with MarketBeat.com's FREE daily email newsletter.